OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase I/Ib Trial of the MUC1 Inhibitor GO-203-2C Alone and in Combination with Decitabine for Acute Myeloid Leukemia

HTML

Year: 2017
Type: article
Source: Blood
DOI: 10.1182/blood.v130.suppl_1.2659.2659
Authors: Jessica Liegel, Jacalyn Rosenblatt, Richard M. Stone, Malgorzata McMasters, James D. Levine, Myrna Nahas, Robin Joyce, Salvia Jain, Daniel J. DeAngelo, Jacqueline S. Garcia, Josie Bazemore, Ilene Galinsky, Donna Neuberg, Lillian Werner, Emma Logan, Kaleb Mikami, Mary Paty Bryant, Victoria E. Allen, Dina Stroopinsky, Leandra Cole, Abigail Washington, Adam Ephraim, David Avigan
Institutions: Beth Israel Deaconess Medical Center, Harvard University, Dana-Farber Cancer Institute
Language: English

Topic: Acute Myeloid Leukemia Research
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W3081774912
FWCI: 0.179
Cites:
Cited by: 4
Related to: 20
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms